Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors
Cancer · 2025
DOI: 10.1002/cncr.35940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Jessica Gartrell und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Cardiotoxicity, Neoplasms, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: St. Jude Children's Research Hospital, American Lebanese Syrian Associated Charities.
Abstract (Originalsprache)
Background
Multitargeted tyrosine kinase inhibitors (MTKIs) have increasingly been used for the treatment of pediatric and young adult patients with solid tumors. Whereas cardiac toxicity is documented in adults, data remain limited in pediatrics. This study sought to characterize the incidence and outcomes of acute cardiotoxicity in pediatric patients with solid tumors treated with an MTKI.
Methods
A retrospective review was conducted of patients who received MTKIs from 2000 to 2021 at St. Jude Children’s Research Hospital. Analyses included patient and disease characteristics, treatment specifics, and measurements of cardiotoxicity (ejection fraction [EF], 2 for left atrial end‐systolic volume index, left ventricular end‐diastolic diameter, and left ventricular end‐systolic diameter). Hypertension (HTN) was evaluated independently, and defined with American Academy of Pediatrics clinical practice guidelines and American College of Cardiology/American Heart Association HTN guidelines.
Results
Among 112 patients, 73 (65%) underwent echocardiography during MTKI therapy. Of 56 patients without prior cardiotoxicity, 17 (32.1%) developed cardiac toxicity during treatment. Of 48 patients without preexisting HTN, 36 (72%) developed HTN at 6 months. Abnormal GLS was the most frequent new‐onset cardiac finding (29.5% at 6 months). Of 61 patients with sequential echocardiograms, 51.4% had a ≥5% decline in EF but only 3.6% required MTKI dose reductions as a result of cardiotoxicity.
Conclusions
Despite changes in cardiac function while on MTKIs, reductions because of cardiac toxicity were infrequent. Routine monitoring of cardiac function during MTKI use and early intervention may enable patients to continue therapy while safeguarding cardiovascular health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Nursing, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Pediatrics, University of Iowa Stead Family Children's Hospital, Carver College of Medicine, Iowa City, Iowa, USA.
ORCID-Profile: Jessica Gartrell, Sara M Federico, Alberto S Pappo
Förderung
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities
Zitieren
APA
Gartrell, J., Mulrooney, D. A., Hsu, C. W., Pan, H., Federico, S. M., Pappo, A. S., Helmig, S., Meredith, C. J., Pease, P., Christensen, A. M., Beasley, G., & Bishop, M. W. (2025). Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors. Cancer. https://doi.org/10.1002/cncr.35940
Vancouver
Gartrell J, Mulrooney DA, Hsu CW, Pan H, Federico SM, Pappo AS, et al. Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors. Cancer. 2025. doi:10.1002/cncr.35940
BibTeX
@article{Gartrell2025,
author = {Gartrell, Jessica and Mulrooney, Daniel A and Hsu, Chia-Wei and Pan, Haitao and Federico, Sara M and Pappo, Alberto S and Helmig, Sara and Meredith, Carly J and Pease, Patricia and Christensen, Anthony M and Beasley, Gary and Bishop, Michael W},
title = {Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35940}
}
EUVIMED